Pain and Fear of Venous Blood Collection in Children

NCT ID: NCT05301088

Last Updated: 2022-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

126 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-01

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nurses are in the position of primary health care provider in relieving children's pain and fears of bloodletting in the wards where they work. As a result of this study, it is aimed to encourage nurses to apply non-pharmacological interventions during painful medical procedures, to facilitate the provision of necessary and different means of distraction to blood collection services, and to contribute to the development of in-house health policies and the preparation of appropriate clinical guides and to add an innovative perspective.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Fear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chocolate Scent

Group Type EXPERIMENTAL

Chocolate Scent

Intervention Type OTHER

Chocolate Scent:Children in this group will be given chocolate scent sniffing as a non-pharmacological distraction method.

Stress Ball:Stress ball squeezing will be used as a non-pharmacological distraction method for children in this group.

Stress Ball

Group Type EXPERIMENTAL

Chocolate Scent

Intervention Type OTHER

Chocolate Scent:Children in this group will be given chocolate scent sniffing as a non-pharmacological distraction method.

Stress Ball:Stress ball squeezing will be used as a non-pharmacological distraction method for children in this group.

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chocolate Scent

Chocolate Scent:Children in this group will be given chocolate scent sniffing as a non-pharmacological distraction method.

Stress Ball:Stress ball squeezing will be used as a non-pharmacological distraction method for children in this group.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Stress Ball

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 6-12 age group,
* children who need blood drawn for any reason
* have no disease that can cause chronic pain,
* no olfactory disorder
* no mental or neurological problems
* able to communicate
* speaks Turkish

Exclusion Criteria

* those who did not give consent to the research by both the child and the parent
Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MSc Eylem Nazan KAPAN

UNKNOWN

Sponsor Role collaborator

Ataturk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Türkan Kadiroğlu

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ataturk University

Erzurum, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B.30.2.ATA.O.O.0l 0/184

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VACCINE HESITATION
NCT06222996 ENROLLING_BY_INVITATION NA